Exosens (CHIX:EXENSP) 3-Year EBITDA Growth Rate: 12.00% (As of Dec. 2025) — 39% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:EXENSP Exosens SA CHIX:EXENSP
42 GF Score
Price €63.70
! 7 Warning Signs
View Full Analysis

What is Exosens 3-Year EBITDA Growth Rate?

Exosens CHIX:EXENSP 42 3-Year EBITDA Growth Rate is 12.00% as of Dec. 2025, which is 39% below its 10-year median of 19.65. GuruFocus rates CHIX:EXENSP with a GF Score™ of 42/100. The stock has 7 warning signs investors should review. Among 2,593 Industrial Products companies, Exosens ranks better than 64.56% on this metric.

Exosens's EBITDA per Share for the six months ended in Dec. 2025 was €1.03.

During the past 12 months, Exosens's average EBITDA Per Share Growth Rate was -15.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Exosens was 27.30% per year. The lowest was 12.00% per year. And the median was 19.65% per year.


Exosens  (CHIX:EXENSp) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Exosens 3-Year EBITDA Growth Rate Related Terms


CHIX:EXENSP vs VRT, BE, HUBB: 3-Year EBITDA Growth Rate Comparison

For the Electrical Equipment & Parts subindustry, Exosens's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exosens 3-Year EBITDA Growth Rate vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Exosens's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Exosens's 3-Year EBITDA Growth Rate falls into.


CHIX:EXENSP
42GF Score
Exosens SA CHIX:EXENSP
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exosens 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 12.00% mean?
Exosens (CHIX:EXENSP) has a 3-Year EBITDA Growth Rate of 12.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Exosens and its competitors. This is 39% below median its historical median of 19.65. Over the past decade, Exosens' 3-Year EBITDA Growth Rate has ranged from 12.00 to 27.30. According to the industry distribution chart, Exosens ranks #919 out of 2593 companies in the Industrial Products industry, placing it in the top 35.4%.
Is Exosens' 3-Year EBITDA Growth Rate too high?
Exosens' current 3-Year EBITDA Growth Rate of 12.00% is 39% below median its 10-year median of 19.65. Over the past 10 years, this metric has ranged from a low of 12.00 to a high of 27.30. The Industrial Products industry median 3-Year EBITDA Growth Rate is 4.40. Exosens' value of 12.00% is 172.7% above this industry median. Based on the distribution chart, Exosens ranks #919 out of 2593 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Exosens has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' 3-Year EBITDA Growth Rate compare to VRT and BE?
According to the Industrial Products industry distribution chart, Exosens ranks #919 out of 2593 companies for 3-Year EBITDA Growth Rate. This puts Exosens in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 4.40. Exosens' value of 12.00% is 172.7% above this benchmark. Historically, Exosens' own 3-Year EBITDA Growth Rate has ranged from 12.00 to 27.30 over the past decade. While the company's 10-year median is 19.65 vs. the industry median of 4.40, Exosens has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Industrial Products company?
The median 3-Year EBITDA Growth Rate among Industrial Products companies is 4.40, based on 2,593 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Exosens's current 3-Year EBITDA Growth Rate of 12.00% is 172.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Exosens and its competitors. For the Industrial Products industry, the median 3-Year EBITDA Growth Rate is 4.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exosens's current 3-Year EBITDA Growth Rate is 12.00%, which is 39% below median its own 10-year median of 19.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (CHIX:EXENSP) has a current 3-Year EBITDA Growth Rate of 12.00%. The current 3-Year EBITDA Growth Rate is 12.00%, which is 39% below median its 10-year median of 19.65 and 172.7% above the Industrial Products industry median of 4.40. Exosens' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Exosens (CHIX:EXENSP), the current 3-Year EBITDA Growth Rate is 12.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
42GF Score

Get the complete analysis for CHIX:EXENSP

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.70
Price